BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2015
View Archived Issues
Strategic Science and Technologies begins phase I study of topical sildenafil
Read More
RiVax ricin toxin vaccine protective in macaque model
Read More
Bio-Path initiates phase II trial of BP-100-1.01 in patients with AML
Read More
Panoptes Pharma concludes license agreement with Mediolanum for PP-001
Read More
Vaxxas' Series B financing to fund vaccine development
Read More
Hyperion initiates pediatric study of Ravicti for urea cycle disorders
Read More
Apellis Pharmaceuticals begins phase I testing of APL-2
Read More
Galapagos, Rega Institute and University Hospital of Heidelberg receive HBV therapy grant
Read More
Novo Nordisk funds diabetes research at Karolinska Institutet
Read More
Repurposed sorafenib shows promising antiviral activity
Read More
Emergent BioSolutions presents results of phase II study of AV-7909 for anthrax
Read More
Actelion patents LXA4R agonists
Read More
NeED Pharma presents new viral entry inhibitors
Read More
Italian and U.S. scientists disclose dual FAAH inhibitors/DRD3 modulators
Read More
MMV, Drexel University and University of Washington patent new antimalarials
Read More
Novartis patent reports new complement factor B inhibitors
Read More
GSK acquires vaccine company GlycoVaxyn
Read More
FDA grants orphan drug designation to Reolysin for ovarian cancer
Read More
Heron Therapeutics begins phase I study of HTX-011
Read More
Valneva completes Dukoral acquisition
Read More
Enzo Biochem develops flow cytometry assay for cervical cancer prognosis
Read More
FDA advisory committees set date to jointly review talimogene laherparepvec BLA
Read More
AbbVie seeks Japanese approval for oral two direct-acting antiviral treatment for HCV
Read More
Anika Therapeutics files for U.S. and E.U. approval of Cingal for osteoarthritis of the knee
Read More
Synthetic Biologics reports topline data from phase Ib trial of SYN-004
Read More